taiwan

Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in lupus

Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in lupus

Hydroxychloroquine is widely used to treat certain viral and rheumatic diseases including systemic lupus erythematosus. Cardiac arrhythmia is an important safety issue with hydroxychloroquine. The aim of this study was to investigate whether hydroxychloroquine increases new-onset arrhythmia among patients with systemic lupus erythematosus.